行情

LIFE

LIFE

aTyr制药
NASDAQ

实时行情|Nasdaq Last Sale

11.56
+1.34
+13.11%
交易中 13:25 09/21 EDT
开盘
10.63
昨收
10.22
最高
11.75
最低
10.35
成交量
546.79万
成交额
--
52周最高
12.97
52周最低
2.930
市值
2.97亿
市盈率(TTM)
-5.0384
分时
5日
1月
3月
1年
5年
Piper Sandler 以增持评级开始对 aTyr Pharma 的报道,宣布目标价为 19 美元
Piper Sandler analyst Edward Tenthoff initiates coverage on aTyr Pharma (NASDAQ:LIFE) with a Overweight rating and announces Price Target of $19.
Benzinga · 8小时前
Love Hemp Group PLC 宣布变更注册办事处
one of the UK's leading CBD and hemp product suppliers, announces that it has changed its registered office to Suite 1, 15 Ingestre Place, London, W1F 0DU from 14 September 2021.
ACCESSWIRE · 1天前
为什么卵巢癌药物市场的制药公司在研发上押注重金 - 财经新闻媒体
Palm Beach, FL - September 17, 2021 – FinancialNewsMedia.com News Commentary – The ovarian cancer drugs market consists of sales of ovarian cancer drugs to treat ovarian cancer. Ovarian cancer is caused due to abnormal growth of cells in ovary. This indust...
MENAFN · 3天前
ATyr Pharma 股价走高; Tang Capital Partners 在 13G 报告中提交了 6.3% 的股份
-SEC Filing
SEC Filing · 4天前
为什么卵巢癌药物市场中的制药公司在研发上押下重注
, /PRNewswire/ -- - The ovarian cancer drugs market consists of sales of ovarian cancer drugs to treat ovarian cancer. Ovarian cancer is caused due to abnormal growth of cells in ovary. This industry includes establishments that produce drugs used in che...
PR Newswire - PRF · 4天前
Love Hemp 收到最初的亚马逊订单
one of the UK's leading CBD and hemp product suppliers, is pleased to announce that it has received its initial order from Amazon.
ACCESSWIRE · 4天前
aTyr Pharma 将于美国东部时间 2021 年 9 月 22 日星期三下午 3:45 在奥本海默秋季医疗保健生命科学和医疗技术峰会上发表演讲。
aTyr Pharma, Inc. (NASDAQ:LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that Sanjay S. Shukla, M.D., M.S., President
Benzinga · 4天前
aTyr Pharma 将出席奥本海默秋季医疗保健生命科学和 MedTech 峰会
SAN DIEGO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that Sanjay S. Shukla, M.D., M.S....
GlobeNewswire · 4天前
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解LIFE最新的财务预测,通过LIFE每股收益,每股净资产,每股现金流等数据分析aTyr制药近期的经营情况,然后做出明智的投资选择。
分析师评级

5位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测LIFE价格均价为19.40,最高价位21.00,最低价为18.00。
EPS
机构持股
总机构数: 45
机构持股: 755.97万
持股比例: 44.68%
总股本: 2,568.24万
类型机构数股数
增持
11
107.62万
建仓
7
12.63万
减持
5
16.93万
平仓
3
2.52万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
+1.30%
制药与医学研究
+0.78%
高管信息
Non-Executive Chairman/Independent Director
John Clarke
President/Chief Executive Officer/Director
Sanjay Shukla
Chief Financial Officer
Jill Broadfoot
General Counsel/Secretary
Nancy Denyes
Director
Sara Zaknoen
Independent Director
Timothy Coughlin
Independent Director
Jane Gross
Independent Director
Svetlana Lucas
Independent Director
Paul Schimmel
暂无数据
LIFE 简况
aTyr Pharma Inc是一家美国的生物技术公司。该公司从事基于生物学的药物开发业务。该公司的研发工作集中在新发现的生物学,细胞外功能和信号通路。

微牛提供aTyr Pharma Inc(NASDAQ-LIFE)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的LIFE股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易LIFE股票基本功能。